CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer—A Multicenter Analysis

by Berchuck, A., Bjorge, L., Defazio, A., Djedovic, V., Glasspool, R., Goode, E.L, Goodman, M.T, Høgdall, C.K, Høgdall, E., Jensen, A., Johnatty, S.E, Karlan, B.Y, Kjaer, S.K, Lajkosz, K., Lambrechts, D., Lester, J., Matsuo, K., May, T., Modugno, F., Pejovic, T., Riggan, M.J, Roxburgh, P., Schildkraut, J.M, Thompson, P.J, Thomsen, L.C.V, Tone, A., Webb, P.M, Winham, S.J, Wohlmuth, C.
Published 2022

Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association

by Anton-Culver, H., Berchuck, A., Chang-Claude, J., Cho, K., Cramer, D., Doherty, J.A, Fortner, R.T, Goodman, M.T, Hanley, G.E, Harris, H.R, Jensen, A., Jordan, S.J, Khoja, L., Kjaer, S.K, Lee, A.W, McLean, K., Modugno, F., Moysich, K., Mukherjee, B., Muthukumar, A., Pearce, C.L, Phung, M.T, Pike, M.C, Risch, H., Schildkraut, J.M, Terry, K.L, The Australian Ovarian Cancer Study Group, Webb, P.M, Weber, R.P, Wu, A.H, Ziogas, A.
Published 2022

High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival

by Anton-Culver, H., Bakulski, K.M, Bandera, E.V, Berchuck, A., Bowtell, D.D.L, Brenton, J.D, Brieger, K.K, Chase, A., Cho, K.R, Cramer, D.W, DeFazio, A., Doherty, J.A, Fereday, S., for the Ovarian Cancer Association Consortium, Fortner, R.T, Gentry-Maharaj, A., Goode, E.L, Goodman, M.T, Grout, B., Hanley, G.E, Harris, H.R, Khoja, L., Matsuo, K., McKinnon Deurloo, C., McLean, K., Menon, U., Modugno, F., Moysich, K.B, Mukherjee, B., Nelson, B.H, Odunsi, K., Pearce, C.L, Pharoah, P.D.P, Phung, M.T, Pike, M.C, Qin, B., Ramus, S.J, Richardson, J., Risch, H.A, Rossing, M.A, Schildkraut, J.M, Terry, K.L, Trabert, B., Vierkant, R.A, Webb, P.M, Wentzensen, N., Winham, S.J, Wu, A.H, Ziogas, A.
Published 2022